GO
Loading...

Acorda CEO: Ampyra Helping Stroke Victims Walk Better

Monday, 15 Apr 2013 | 6:15 PM ET

Acorda Therapeutics CEO Dr. Ron Cohen discusses what his company has planned for 2013, and how Ampyra is helping people with post-stroke deficits.